Yang Zhao

发表

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

Min Yi, Jing Wang, Yang Zhao, 2017, Nature Communications.

Challenges and Strategies in Ascribing Functions to Long Noncoding RNAs

Li Ma, Yutong Sun, Yang Zhao, 2020, Cancers.

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

Dana Pe’er, Yang Zhao, D. Pe’er, 2017, Cell.

Macrophage depletion through colony stimulating factor 1 receptor pathway blockade overcomes adaptive resistance to anti-VEGF therapy

K. Baggerly, A. Sood, P. Hwu, 2017, Oncotarget.

Negative Co‐stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell States

D. Pe’er, M. Setty, Jacob H. Levine, 2019, Immunity.

A miR-SNP biomarker linked to an increased lung cancer survival by miRNA-mediated down-regulation of FZD4 expression and Wnt signaling

Jing Wang, J. Gu, Xifeng Wu, 2017, Scientific Reports.

Defining Survivorship Trajectories Across Patients With Solid Tumors: An Evidence-Based Approach

K. Baggerly, A. Sood, R. Coleman, 2018, JAMA oncology.

Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.

S. Hanash, A. Maitra, M. Tempero, 2016, Journal of the National Cancer Institute.

EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma

F. Gao, W. Yung, S. Sen, 2022, Neuro-oncology.

TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

Jing Wang, J. Roth, V. Baladandayuthapani, 2016, Scientific Reports.

High-throughput profiling of signaling networks identifies mechanism-based combination therapy to eliminate microenvironmental resistance in acute myeloid leukemia

K. Baggerly, M. Konopleva, M. Andreeff, 2017, Haematologica.

Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study.

K. Baggerly, M. Konopleva, K. Patel, 2019, Clinical lymphoma, myeloma & leukemia.

Elevation of TP53 Autoantibody Before CA125 in Preclinical Invasive Epithelial Ovarian Cancer

K. Baggerly, R. Bast, D. Bowtell, 2017, Clinical Cancer Research.

A targetable LIFR−NF-κB−LCN2 axis controls liver tumorigenesis and vulnerability to ferroptosis

Li Ma, D. Xie, Jenny C. Chang, 2021, Nature Communications.

Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models

Jing Wang, M. Konopleva, M. Andreeff, 2019, Haematologica.

Clinical candidate and genistein analogue AXP107‐11 has chemoenhancing functions in pancreatic adenocarcinoma through G protein‐coupled estrogen receptor signaling

Jing Wang, A. Berkenstam, Chin-Yo Lin, 2019, Cancer medicine.

Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in CRLF2 rearranged and/or JAK driven Philadelphia chromosome–like acute B-cell lymphoblastic leukemia

Jing Wang, C. Mullighan, M. Konopleva, 2018, Oncotarget.

Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer.

Xian Chen, Jing Wang, K. Hunt, 2018, Cancer research.

Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance

Jun Yao, Li Ma, M. Hung, 2021, Nature Communications.

Genetic rescue of lineage-balanced blood cell production reveals a crucial role for STAT3 antiinflammatory activity in hematopoiesis

Erika J. Thompson, Jing Wang, G. Garcia-Manero, 2018, Proceedings of the National Academy of Sciences.

Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer

S. Hanash, A. Maitra, M. Tempero, 2017, Journal of the National Cancer Institute.

MAPRE1 as a Plasma Biomarker for Early-Stage Colorectal Cancer and Adenomas

S. Hanash, R. Kucherlapati, R. DePinho, 2015, Cancer Prevention Research.

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)

Jing Wang, J. Roth, B. Dai, 2017, Oncotarget.

A miR-SNP biomarker linked to an increased lung cancer survival by miRNA-mediated down-regulation of FZD4 expression and Wnt signaling

Jing Wang, J. Gu, Xifeng Wu, 2017, Scientific Reports.

Serum MicroRNA‐150 Predicts Prognosis for Early‐Stage Non‐Small Cell Lung Cancer and Promotes Tumor Cell Proliferation by Targeting Tumor Suppressor Gene SRCIN1

Jing Wang, J. Gu, Xifeng Wu, 2018, Clinical pharmacology and therapeutics.

A genetic mouse model recapitulates immune checkpoint inhibitor-associated myocarditis and supports a mechanism-based therapeutic intervention.

Jing Wang, Y. Li, P. Sharma, 2020, Cancer discovery.

Glucocorticoid receptor regulates PD-L1 and MHC-I in pancreatic cancer cells to promote immune evasion and immunotherapy resistance

Jun Yao, Li Ma, M. Hung, 2021, Nature communications.

LIFR recruits HGF-producing neutrophils to promote liver injury repair and regeneration

Li Ma, Chunru Lin, Hao Zhu, 2023, bioRxiv.

Function of T follicular helper cells in anti-tumor immunity

R. Nurieva, Shayahati Bieerkehazhi, Yang Zhao, 2019, The Journal of Immunology.

c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun

Y. Qi, N. Gray, Tinghu Zhang, 2017, Oncogene.

Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer.

S. Hanash, A. Maitra, M. Tempero, 2017, Journal of the National Cancer Institute.